Submitted by Anonymous (not verified) on 18 August 2026 - 16:58
Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Herwenda, trastuzumab, Date of authorisation: 15/11/2023, Revision: 3, Status: Authorised